Related Experiment Videos
Functional interaction between the glucocorticoid receptor and GANP/MCM3AP.
Waffa Osman1, Sanna Laine, Johanna Zilliacus
1Department of Biosciences and Nutrition, Karolinska Institutet, Novum, SE-141 86 Huddinge, Sweden.
Biochemical and Biophysical Research Communications
|August 18, 2006
Summary
Glucocorticoids inhibit cell proliferation, but researchers found GANP/MCM3AP interacts with the glucocorticoid receptor, potentially regulating this effect. Overexpression of MCM3AP prevented glucocorticoid-induced proliferation inhibition.
Area of Science:
- Cell Biology
- Molecular Biology
- Endocrinology
Background:
- Glucocorticoids treat inflammatory diseases but cause side effects linked to inhibited cell proliferation.
- Glucocorticoid action is mediated by binding to the glucocorticoid receptor.
- Understanding glucocorticoid receptor interactions is crucial for managing side effects.
Purpose of the Study:
- Identify novel proteins interacting with the glucocorticoid receptor.
- Investigate the role of these interactions in glucocorticoid-mediated cell proliferation.
- Elucidate the mechanism by which glucocorticoids affect cell division.
Main Methods:
- Two-hybrid screens to identify interacting proteins.
- Glutathione-S-transferase pull-down and co-immunoprecipitation assays.
- Cellular localization studies and functional assays in HeLa cells.
Main Results:
- Identified germinal center-associated protein (GANP) and its splicing variant MCM3-associated protein (MCM3AP) as glucocorticoid receptor interacting proteins.
- Demonstrated interaction between the C-terminal domain of GANP (including MCM3AP) and the ligand-binding domain of the glucocorticoid receptor.
- Showed that overexpression of MCM3AP prevents glucocorticoid-induced inhibition of DNA replication in HeLa cells.
Conclusions:
- GANP and MCM3AP are novel glucocorticoid receptor interacting proteins.
- The GANP/MCM3AP complex plays a role in regulating cell proliferation in response to glucocorticoids.
- Targeting the glucocorticoid receptor-GANP/MCM3AP interaction may offer therapeutic strategies to mitigate glucocorticoid side effects.